NATCO PHARMA
|
NATCO PHARMA Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹4,332 Cr | ₹2,881 Cr | ₹2,216 Cr | ₹2,084 Cr | ₹2,058 Cr |
Sales | ₹3,958 Cr | ₹2,799 Cr | ₹1,947 Cr | ₹1,697 Cr | ₹1,856 Cr |
Job Work/ Contract Receipts | ₹0.90 Cr | ₹7.60 Cr | ₹4.60 Cr | ₹10 Cr | ₹30 Cr |
Processing Charges / Service Income | ₹353 Cr | ₹65 Cr | ₹225 Cr | ₹15 Cr | ₹145 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹20 Cr | ₹10 Cr | ₹40 Cr | ₹362 Cr | ₹27 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹3,999 Cr | ₹2,707 Cr | ₹1,945 Cr | ₹2,052 Cr | ₹1,915 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹43 Cr | ₹-24 Cr | ₹-17 Cr | ₹-48 Cr | ₹-75 Cr |
Raw Material Consumed | ₹625 Cr | ₹607 Cr | ₹545 Cr | ₹532 Cr | ₹430 Cr |
Opening Raw Materials | ₹222 Cr | ₹245 Cr | ₹342 Cr | ₹163 Cr | ₹211 Cr |
Purchases Raw Materials | ₹456 Cr | ₹409 Cr | ₹389 Cr | ₹525 Cr | ₹253 Cr |
Closing Raw Materials | ₹204 Cr | ₹222 Cr | ₹245 Cr | ₹342 Cr | ₹163 Cr |
Other Direct Purchases / Brought in cost | ₹151 Cr | ₹176 Cr | ₹59 Cr | ₹187 Cr | ₹128 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹89 Cr | ₹82 Cr | ₹76 Cr | ₹61 Cr | ₹62 Cr |
Electricity & Power | ₹89 Cr | ₹82 Cr | ₹76 Cr | ₹61 Cr | ₹62 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹525 Cr | ₹487 Cr | ₹445 Cr | ₹415 Cr | ₹375 Cr |
Salaries, Wages & Bonus | ₹473 Cr | ₹438 Cr | ₹391 Cr | ₹353 Cr | ₹313 Cr |
Contributions to EPF & Pension Funds | ₹29 Cr | ₹27 Cr | ₹26 Cr | ₹24 Cr | ₹22 Cr |
Workmen and Staff Welfare Expenses | ₹11 Cr | ₹11 Cr | ₹14 Cr | ₹14 Cr | ₹15 Cr |
Other Employees Cost | ₹11 Cr | ₹11 Cr | ₹14 Cr | ₹24 Cr | ₹25 Cr |
Other Manufacturing Expenses | ₹368 Cr | ₹280 Cr | ₹354 Cr | ₹292 Cr | ₹243 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹70 Cr | ₹66 Cr | ₹60 Cr | ₹54 Cr | ₹51 Cr |
Packing Material Consumed | ₹49 Cr | ₹44 Cr | ₹33 Cr | ₹28 Cr | ₹27 Cr |
Other Mfg Exp | ₹249 Cr | ₹170 Cr | ₹261 Cr | ₹210 Cr | ₹165 Cr |
General and Administration Expenses | ₹313 Cr | ₹209 Cr | ₹153 Cr | ₹117 Cr | ₹133 Cr |
Rent , Rates & Taxes | ₹136 Cr | ₹56 Cr | ₹39 Cr | ₹37 Cr | ₹40 Cr |
Insurance | ₹30 Cr | ₹28 Cr | ₹26 Cr | ₹20 Cr | ₹15 Cr |
Printing and stationery | - | - | - | - | - |
Professional and legal fees | ₹85 Cr | ₹73 Cr | ₹49 Cr | ₹30 Cr | ₹36 Cr |
Traveling and conveyance | ₹50 Cr | ₹37 Cr | ₹22 Cr | ₹16 Cr | ₹26 Cr |
Other Administration | ₹13 Cr | ₹15 Cr | ₹16 Cr | ₹14 Cr | ₹17 Cr |
Selling and Distribution Expenses | ₹153 Cr | ₹96 Cr | ₹44 Cr | ₹34 Cr | ₹98 Cr |
Advertisement & Sales Promotion | ₹133 Cr | ₹66 Cr | ₹33 Cr | ₹21 Cr | ₹94 Cr |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | ₹21 Cr | ₹30 Cr | ₹11 Cr | ₹13 Cr | ₹4.50 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹131 Cr | ₹59 Cr | ₹82 Cr | ₹46 Cr | ₹67 Cr |
Bad debts /advances written off | ₹5.10 Cr | ₹11 Cr | ₹20 Cr | ₹12 Cr | ₹5.50 Cr |
Provision for doubtful debts | ₹23 Cr | - | ₹27 Cr | - | ₹18 Cr |
Losson disposal of fixed assets(net) | ₹1.70 Cr | - | - | - | - |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | ₹0.90 Cr | - | - | - | - |
Other Miscellaneous Expenses | ₹101 Cr | ₹48 Cr | ₹35 Cr | ₹34 Cr | ₹44 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹2,247 Cr | ₹1,795 Cr | ₹1,681 Cr | ₹1,448 Cr | ₹1,332 Cr |
Operating Profit (Excl OI) | ₹1,751 Cr | ₹912 Cr | ₹264 Cr | ₹604 Cr | ₹583 Cr |
Other Income | ₹128 Cr | ₹129 Cr | ₹99 Cr | ₹106 Cr | ₹107 Cr |
Interest Received | ₹101 Cr | ₹51 Cr | ₹39 Cr | ₹57 Cr | ₹79 Cr |
Dividend Received | ₹0.30 Cr | ₹0.10 Cr | ₹0.20 Cr | - | - |
Profit on sale of Fixed Assets | - | ₹18 Cr | ₹43 Cr | ₹32 Cr | ₹16 Cr |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | ₹24 Cr | - | ₹2.40 Cr | ₹2.90 Cr |
Foreign Exchange Gains | ₹10 Cr | ₹21 Cr | ₹10 Cr | ₹4.00 Cr | ₹5.10 Cr |
Others | ₹17 Cr | ₹14 Cr | ₹6.80 Cr | ₹11 Cr | ₹4.00 Cr |
Operating Profit | ₹1,880 Cr | ₹1,040 Cr | ₹363 Cr | ₹710 Cr | ₹690 Cr |
Interest | ₹19 Cr | ₹15 Cr | ₹18 Cr | ₹13 Cr | ₹22 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹7.20 Cr | ₹5.00 Cr | ₹4.50 Cr | ₹4.00 Cr | ₹3.80 Cr |
Other Interest | ₹12 Cr | ₹9.50 Cr | ₹13 Cr | ₹9.30 Cr | ₹18 Cr |
PBDT | ₹1,860 Cr | ₹1,026 Cr | ₹345 Cr | ₹697 Cr | ₹669 Cr |
Depreciation | ₹187 Cr | ₹164 Cr | ₹143 Cr | ₹117 Cr | ₹100 Cr |
Profit Before Taxation & Exceptional Items | ₹1,674 Cr | ₹862 Cr | ₹202 Cr | ₹580 Cr | ₹569 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹1,674 Cr | ₹862 Cr | ₹202 Cr | ₹580 Cr | ₹569 Cr |
Provision for Tax | ₹285 Cr | ₹147 Cr | ₹32 Cr | ₹137 Cr | ₹111 Cr |
Current Income Tax | ₹315 Cr | ₹163 Cr | ₹48 Cr | ₹141 Cr | ₹127 Cr |
Deferred Tax | ₹-31 Cr | ₹38 Cr | ₹40 Cr | ₹14 Cr | ₹18 Cr |
Other taxes | ₹1.20 Cr | ₹-53 Cr | ₹-56 Cr | ₹-18 Cr | ₹-34 Cr |
Profit After Tax | ₹1,388 Cr | ₹715 Cr | ₹170 Cr | ₹442 Cr | ₹458 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | ₹-1.50 Cr | ₹2.70 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹1,388 Cr | ₹715 Cr | ₹170 Cr | ₹441 Cr | ₹461 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹3,292 Cr | ₹2,667 Cr | ₹2,568 Cr | ₹2,239 Cr | ₹1,937 Cr |
Appropriations | ₹4,681 Cr | ₹3,382 Cr | ₹2,738 Cr | ₹2,680 Cr | ₹2,398 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | ₹22 Cr |
Other Appropriation | ₹213 Cr | ₹91 Cr | ₹-11 Cr | ₹16 Cr | ₹14 Cr |
Equity Dividend % | ₹475.00 | ₹275.00 | ₹225.00 | ₹262.50 | ₹337.50 |
Earnings Per Share | ₹77.56 | ₹39.19 | ₹9.32 | ₹24.16 | ₹25.32 |
Adjusted EPS | ₹77.56 | ₹39.19 | ₹9.32 | ₹24.16 | ₹25.32 |
Compare Income Statement of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹25,025.6 Cr | -2% | 2.9% | 72% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹451,603.0 Cr | 2.9% | 6.4% | 48.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,862.0 Cr | 0.5% | -2.1% | 59.2% | Stock Analytics | |
CIPLA | ₹122,810.0 Cr | 2.3% | 1% | 20.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,946.0 Cr | 3.5% | 15.7% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,377.1 Cr | -0.1% | 2.3% | 41.1% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -2% |
2.9% |
72% |
SENSEX | 0.3% |
-2.5% |
10% |
You may also like the below Video Courses